- Home
- latin america
- Companies
Refine by
Locations
- Latin America
- Antigua & Barbuda
- Argentina
- Aruba
- Bahamas
- Barbados
- Belize
- Bolivia
- Brazil
- Cayman Islands
- Chile
- Colombia
- Costa Rica
- Cuba
- Dominica
- Dominican Republic
- Ecuador
- El Salvador
- Grenada
- Guatemala
- Guyana
- Haiti
- Honduras
- Jamaica
- Mexico
- Netherlands Antilles
- Nicaragua
- Panama
- Paraguay
- Peru
- Puerto Rico
- St. Kitts & Nevis
- St. Lucia
- St. Vincent & The Grenadines
- Suriname
- Trinidad
- Uruguay
- Venezuela
Industries served
- Medical / Health Care
- Agriculture
- Energy
- Monitoring and Testing
- Water and Wastewater
- Chemical & Pharmaceuticals
- Environmental
- Manufacturing, Other
- Electronics and Computers
- Health and Safety
- Oil, Gas & Refineries
- Aerospace & Air Transport
- Metal
- Air and Climate
- Plastics & Resins
- Waste and Recycling
- University / Academia / Research
- Food and Beverage
- Mining
- Automobile & Ground Transport
- Banking & Finance / Insurance / Legal
- Defense
- Paint
- Communications / Telecom / Datacom
- Construction & Construction Materials
- Furniture
- Dry Cleaning
- Domestic
- Forestry & Wood
- Glassware
- Packaging
- Commercial
- Logistics
- Leather & Tanning
- Printing
- Textile
- Soil and Groundwater
- Government
Medical Industry Technology Serving Latin America
490 companies found
Technologybased inFrankfurt am Main, GERMANY
We are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses ...
Kearns-Sayre Syndrome (KSS) is a mitochondrial disease, with Rare Disease designation (7,400 – 22,000 patients in Europe), caused primarily by large-scale mitochondrial DNA deletions. Cardiac dysfunction is the principal clinical manifestation ...
Technologybased inParis, FRANCE
Curadigm is an early-stage company focused on shifting the paradigm of therapeutic clearance, bioavailability, and efficacy to improve treatment outcomes for millions of patients. Curadigm was spun-off from Nanobiotix, a late-stage clinical company, ...
Curadigm’s technology was developed to address a critical challenge facing intravenously administered therapeutics: How can you efficiently deliver a drug to your tissue of interest without rapid clearance? To address this, we ...
Technologybased inMountain View, CALIFORNIA (USA)
Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to ...
Technologybased inNaples, FLORIDA (USA)
Enveric Biosciences is leveraging its discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body. By harnessing the power of synthetic biology and ...
Every molecule in the Psybrary™ is screened through PsyAITM, a proprietary artificial intelligence (AI) tool. Leveraging AI systems reduces the time and cost of commercial development. It streamlines pharmaceutical design by predicting ideal ...
Technologybased inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
We have also developed another class of compounds that are novel histone deacetylase inhibitors (HDACi). Designated as our LB-200 series of compounds, these have potential use in the prevention and treatment of neurodegenerative diseases. The series ...
Technologybased inChester, UNITED KINGDOM
Byotrol's first antimicrobial technology was invented over 20 years ago, and since then we have developed a number of biocidal technologies and antimicrobial test methods, which challenge traditional disinfectant products and methods of cleaning, to ...
Technologybased inHerzliya, ISRAEL
OsteoSee is a clinical-stage company focused on bringing bone health screening and monitoring to the place where they will bring the highest benefit – the primary care clinic and the home. OsteoSee ClinicTM uses the company's proprietary parametric ...
By inventing an innovative, validated approach to assess Bone Mineral Density, we can bring huge user and patient benefits that far surpass existing solutions. With a successful proof of concept and two clinical trials with over 600 patients in ...
Technologybased inRegensburg, GERMANY
numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...
Cancer is among the leading causes of death worldwide. Approximately 38 % of men and women will be diagnosed with cancer at some point during their lifetimes (based on 2013 – 2015 data1). Cancer can occur in any organ and in any cell ...
Technologybased inEindhoven, NETHERLANDS
Our work builds on decades of research and translational science by giants in this important and emerging field. We were formed in 2014 by researchers at the Swiss Federal Institute of Technology (EPFL). We are now headquartered at the High Tech ...
Technologybased inGuangzhou, CHINA
Guangzhou Pluslife Biotech Co., Ltd. established in Guangzhou, China in 2017. With our R&D team that combines experienced and talented researching and developing personnel that more than 60% of them are certificated Ph.Ds or Masters, our team ...
Technologybased inYokohama, JAPAN
BL Dynamics Inc. offers various lines of products producing ultrafine bubbles. Bubbles smaller than 50µm in diameter have unique properties which are different from larger bubbles. We have delivered our system, Nano-BL special aeration, to many ...
The advantage of a nozzle-type micro/nano bubble generator is the uniformity of bubble sizes. Uniformly sized micro/nano bubbles are less liable to get together and able to maintain the properties of micro bubbles relatively well. Incorporating it ...
Technologybased inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
Technologybased inEttlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...
Therapy of HCC depend on the size and location of the tumor, how well the liver is functioning, and the overall health of the patient. ...
Technologybased inMiami, FLORIDA (USA)
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...
Our lead product, Lomecel-B, consists of human allogeneic bone-marrow derived MSCs as the active ingredient. These cells undergo cultured-expansion using proprietary processes, and are then formulated, packaged and stored frozen (cryopreserved) ...
Technologybased inMawson Lakes, AUSTRALIA
Carina Biotech is an Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. CAR-T therapy is a revolutionary new treatment option that uses a ...
Carina Biotech's proprietary manufacturing process leads to a greater efficiency in CAR-T cell ...
Technologybased inAlhambra, CALIFORNIA (USA)
ApolloMed is a physician-centric, technology-powered healthcare delivery company. We are a pure-play value-based care platform that empowers physicians with the tools and technologies to make their jobs easier, so they can provide the best possible ...
Since 2019, ApolloMed has placed a renewed focus on its technologies, building a team of world-class technologists to develop proprietary end-to-end solutions that drive tangible results for providers and improved outcomes and experiences for ...
Technologybased inRandersacker, GERMANY
Nowadays, medical technology has to try to keep up with medical research and respond to the increased demands of both doctors and patients. The rapidly developing field of sleep medicine in particular requires innovative solutions. Coming from the ...
4kHz sample rate with 24 Bit resolution, Automatic sensor & electrode recognition, Robust design but still allows bedside bio-calibration, Shortest EEG Electrode with Continuous Impedance Check, Add video to help identify events and artefacts, ...
Technologybased inEdogawa-ku, JAPAN
B dot Medical Inc. is a QST/ NIRS startup company which has the advanced technology and know-how developed and accumulated in the development of particle therapy system at NIRS. We develop the 'ultra-compact proton therapy system' that defied common ...
We are trying to overturn the image that society has of radiotherapy and proton therapy with our innovative technology. We are developing proton therapy with the hope of making it accessible to all cancer ...
Technologybased inWhite Plains, NEW YORK (USA)
Oligomerix is a biotechnology company focused on developing disease-modifying and treatment therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy ...
There exist numerous rare diseases that tau dysfunction is associated with known as tauopathies. While Alzheimer’s is the largest tauopathy, other tauopathies are rare diseases that present accelerated regulatory pathways and significant ...
Technologybased inSchlieren, SWITZERLAND
We want to empower people to deal with their malignant cells through their own immune system just like we deal with viral infections. Today’s cancer immunotherapies are powerful but, to the detriment of their effect, not very tumor-selective. ...
